Ritlecitinib

ATC L04AF08 · 11 markets · 14 records

Ritlecitinib 11 markets · 14 records Forms

AU 3 records · 2 strengths

  • 80.128 mgcapsuleLITFULO ritlecitinib (as tosylate) 50 mg hard capsule blister packLITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle unknown

Records without a stated strength · 1 Litfulo

US 2 records · 1 strengths

GB 1 records · 1 strengths

CA 1 records · 1 strengths

SG 1 records · 1 strengths

CN 1 records · 1 strengths

ES 1 records · 1 strengths

MX 1 records · 1 strengths

    Records without a stated strength · 1 Litfulo

    TW 1 records · 1 strengths

    • 50 mgcapsuleLitfulo立服樂50毫克膠囊 also in US·GB·CA +3

    HK 1 records · 1 strengths

      Records without a stated strength · 1 Litfulo

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Litfulo

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.